CTLA4 and neoplasm: Also, programmed death ligand 2 (PD-L2) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) were expressed on SGC tumor cells at frequencies of 63% and 74.1%, respectively, whereby PD-L2 expression was associated with a shorter progression-free survival [13].